Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of XL999 in Patients With Acute Myeloid Leukemia (AML)

This study has been terminated.
(Study was terminated due to cardiac toxicities)
Sponsor:
Information provided by:
Symphony Evolution, Inc.
ClinicalTrials.gov Identifier:
NCT00322673
First received: May 4, 2006
Last updated: February 18, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)